Fundraising Fox
/Companies
Sign in

Firefly Neuroscience

NASDAQ: AIFF

Kenmore, US · Founded 2021 · Delaware corporation

Find your way into Firefly Neuroscience

Sign up to see every warm intro you have to Firefly Neuroscience

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Firefly Neuroscience team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Firefly develops neurodiagnostic technology that combines quantitative EEG (qEEG) and event-related potentials (ERP) to assess brain function, analyzing recordings against an FDA-cleared, age-matched normative database. Its tools support clinicians in evaluating cognitive disorders and enable collaboration with CNS drug developers on biomarkers, clinical trials, and companion diagnostics.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

GLGreg Lipschitz
Greg LipschitzExecutive
DD
David DeCaprioExecutive
PKPaul Krzywicki
Paul KrzywickiExecutive
GI
Gil IssacharExecutiveGil Issachar leads Firefly Neuroscience and has held data science and R&D leadership roles in neurotechnology and medical devices, where he developed AI-driven EEG biomarkers and FDA-regulated brain-health tools in partnership with pharmaceutical companies and clinical institutions.
GLGreg Lipshitz
Greg LipshitzExecutive
JO
Jon OlsenExecutive
SP
Stephen PurcellExecutive
SA
STANLEY A REESEExecutive
MT
MATTHEW T SANDSExecutive

Board

FC
Fred CohenBoard director
AM
Arun MenawatBoard director
BP
Brian PosnerBoard director

Reported raises · per SEC filings

Form D private placements

$21.6M disclosed across 10 of 12 rounds · 2021–2026

▶$2.3MraisedApr 2026 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg LipshitzExecutive Officer, Director
  • David DeCaprioExecutive Officer, Director
  • Paul KrzywickiExecutive Officer
  • Stella VnookDirector
  • Gil IssacharExecutive Officer
  • Arun MenawatDirector
  • Brian PosnerDirector
Offering amount
$20.3M
Amount sold
$2.3M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedMar 2026 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arun MenawatDirector
  • Stella VnookDirector
  • Gil IssacharExecutive Officer
  • Brian PosnerDirector
  • Paul KrzywickiExecutive Officer
  • David DeCaprioExecutive Officer, Director
  • Greg LipshitzExecutive Officer, Director
Offering amount
$20.3M
Amount sold
$2.3M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJun 2025 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Arun MenawatDirector
  • Greg LipschitzExecutive Officer, Director
  • David DeCaprioExecutive Officer, Director
  • Brian PosnerDirector
  • Paul KrzywickiExecutive Officer
  • Stella VnookDirector
  • Gil IssacharExecutive Officer
Offering amount
$2M
Amount sold
$1.2M
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$375KraisedJun 2023 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon OlsenExecutive Officer, Director
  • Arun MenawatDirector
  • Greg LipshitzDirector
Offering amount
$2M
Amount sold
$375K
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$133.4KraisedApr 2023 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg LipshitzDirector
  • Jon OlsenExecutive Officer, Director
  • Fred CohenDirector
  • Arun MenawatDirector
  • Stephen PurcellExecutive Officer
Offering amount
$133.4K
Amount sold
$133.4K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedAug 2022 · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • TIMOTHY G HANNONExecutive Officer
  • MARK T KRIALDirector
  • PAUL B BECKERDirector
  • DONALD J TRINGALIDirector
  • GERALD JAMES BENOIT, JRExecutive Officer, Director
  • LINDA L SINGHDirector
  • WILLIAM H PICKLEDirector
  • JAMES C DiPAULADirector
  • BONNIE K WACHTELDirector
  • JACK L JOHNSON, JRDirector
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MofferedJul 2022 · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • WILLIAM H PICKLEDirector
  • DONALD J TRINGALIDirector
  • LINDA L SINGHDirector
  • GERALD JAMES BENOIT, JRExecutive Officer, Director
  • BONNIE K WACHTELDirector
  • MARK T KRIALDirector
  • PAUL B BECKERDirector
  • JACK L JOHNSON, JRDirector
  • JAMES C DiPAULADirector
  • TIMOTHY G HANNONExecutive Officer
Offering amount
$15M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedDec 2021 · 105 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES C DiPAULA, JRDirector
  • TIMOTHY G HANNONExecutive Officer
  • MARK T KRIALDirector
  • JACK L JOHNSON, JRDirector
  • WILLIAM H PICKLEDirector
  • PAUL B BECKERDirector
  • DONALD J TRINGALIDirector
  • BONNIE K WACHTELDirector
  • GERALD JAMES BENOIT, JRExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
Minimum investment
$30.4K
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Firefly Neuroscience do?
Firefly develops neurodiagnostic technology that combines quantitative EEG (qEEG) and event-related potentials (ERP) to assess brain function, analyzing recordings against an FDA-cleared, age-matched normative database. Its tools support clinicians in evaluating cognitive disorders and enable collaboration with CNS drug developers on biomarkers, clinical trials, and companion diagnostics.
How much funding has Firefly Neuroscience raised?
Firefly Neuroscience has disclosed $21.6M raised across 10 of its 12 known rounds.
Where is Firefly Neuroscience headquartered?
Firefly Neuroscience is headquartered in Kenmore, US.